sglt2 inhibitors and glp-1 receptor agonists together in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy | Drugs SGLT2 Inhibitors and GLP-1 Receptor

22 However, the fact that the magnitude and speed of hemoglobin A1c reduction with treatment were identified as risk factors for progression suggests it could be another example of the well-established early worsening phenomenon first observed in type 1 diabetic patients intensively treated with insulin in the Oslo Study, Kroc Collaborative Study and Diabetes Control and Complications Trial

[DOI] [PubMed] [Google Scholar] 104.Kolb P., Kenakin T., Alexander S.P.H., Bermudez M., Bohn L.M., Breinholt C.S., Bouvier M., Hill S.J., Kostenis E., Martemyanov K.A., et al

Around four months after he started taking Ozempic, Todd lost his vision

July 2024 Study Links Active Ingredient in Some GLP-1 Drugs to Vision Loss A new study published in the Journal of the American Medical Associations Ophthalmology linked semaglutide drugs to a type of eye strokes called nonarteritic anterior ischemic optic neuropathy (NAION)

Increasingly, reports suggest a possible association between GLP-1 RA use and enhanced fertility outcomes, particularly in women with obesity or polycystic ovary syndrome (PCOS)

No, GLP-1 drugs are prescription medications and require approval from a healthcare provider based on your medical history and eligibility